Načítá se...
Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis
BACKGROUND: Patients with end-stage kidney disease (ESKD) treated with hemodialysis (HD) experience many distressing symptoms. One frequently reported symptom is insomnia. There are unique issues about HD treatments and schedules that disrupt regular sleep/wake routines and possibly contribute to th...
Uloženo v:
| Vydáno v: | BMC Nephrol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574396/ https://ncbi.nlm.nih.gov/pubmed/33081705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02107-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|